Epidemiology, diagnosis and treatment of moyamoya disease (Review)
- Authors:
- Hui Zhang
- Lijian Zheng
- Lei Feng
-
Affiliations: Department of Neurosurgery, The First People's Hospital of Jining, Jining, Shandong 272011, P.R. China - Published online on: January 25, 2019 https://doi.org/10.3892/etm.2019.7198
- Pages: 1977-1984
This article is mentioned in:
Abstract
 |
|
Takeuchi K and Shimizu K: Hypoplasia of the bilateral internal carotid arteries. Brain Nerve. 9:37–43. 1957. | |
|
Suzuki J and Takaku A: Cerebrovascular ‘moyamoya’ disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 20:288–299. 1969. View Article : Google Scholar : PubMed/NCBI | |
|
Kuroda S and Houkin K: Moyamoya disease: Current concepts and future perspectives. Lancet Neurol. 7:1056–1066. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (moyamoya' disease). Research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) of the ministry of health and welfare, Japan. Clin Neurol Neurosurg. 99 (Suppl 2):S238–S240. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases: Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 52:245–266. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Syndrome Cecgodatomdam and Committee TNCoHS PatoissecoS: Chinese expert consensus on diagnosis and treatment of moyamoya disease and moyamoya syndrome (2017). Chin J Neurosurg. 6:541–547. 2017.(In Chinese). | |
|
Research on intractable diseases of the Ministry of Health Labour and Welfare, Japan: Recommendations for the management of moyamoya disease: A statement from research committee on spontaneous occlusion of the circle of Willis (moyamoya disease). Surgery for Cerebral Stroke. 37:321–337. 2009. View Article : Google Scholar | |
|
Piao J, Wu W, Yang Z and Yu J: Research progress of moyamoya disease in children. Int J Med Sci. 12:566–575. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Smith ER and Scott RM: Spontaneous occlusion of the circle of Willis in children: Pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr. 9:353–360. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T and Steinberg GK: Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery. 71:587–593. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kim T, Lee H, Bang JS, Kwon OK, Hwang G and Oh CW: Epidemiology of moyamoya disease in Korea: Based on national health insurance service data. J Korean Neurosurg Soc. 57:390–395. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou XW, Wang JZ and Ma Y: Literature review and current situation of domestic moyamoya disease. Chin J Pract Nerv Dis. 20:1–4. 2017. | |
|
Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ and Cho BK: Headache in pediatric moyamoya disease: Review of 204 consecutive cases. J Neurosurg. 103 Suppl 5:S439–S442. 2005. | |
|
Okada Y, Kawamata T, Kawashima A, Yamaguchi K, Ono Y and Hori T: The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg. 116:672–679. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Baba T, Houkin K and Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 79:900–904. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ and Ahn HS: Incidence, prevalence, and survival of moyamoya disease in Korea: A nationwide, population-based study. Stroke. 45:1090–1095. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kainth D, Chaudhry SA, Kainth H, Suri FK and Qureshi AI: Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology. 40:282–287. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, Huang QJ and Lou ZX: Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg. 112:199–203. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, Zong R, Han C, Zhao F and Feng J: Moyamoya disease in China: Its clinical features and outcomes. Stroke. 43:56–60. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, Takagi Y, Nozaki K, Hashimoto N and Koizumi A: Inheritance pattern of familial moyamoya disease: Autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 77:1025–1029. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ikeda H, Sasaki T, Yoshimoto T, Fukui M and Arinami T: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 64:533–537. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T and Fukui M: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 31:930–935. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M and Arinami T: A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 49:278–281. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, et al: A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 56:34–40. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, et al: Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 6:e225422011. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M and Gu Y: Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One. 7:e481792012. View Article : Google Scholar : PubMed/NCBI | |
|
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, et al: Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 78:803–810. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, Wang GT, Regalado ES, Steinberg GK, Shendure J, et al: RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke. 45:3200–3207. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS and Yoo HW: Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 124:1221–1227. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi H, Brozman M, Kyselová K, Viszlayová D, Morimoto T, Roubec M, Školoudík D, Petrovičová A, Juskanič D, Strauss J, et al: RNF213 rare variants in slovakian and czech moyamoya disease patients. PLoS One. 11:e01647592016. View Article : Google Scholar : PubMed/NCBI | |
|
Raso A, Biassoni R, Mascelli S, Nozza P, Ugolotti E, DI Marco E, DE Marco P, Merello E, Cama A, Pavanello M and Capra V: Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. J Neurosurg Sci. 2016.PubMed/NCBI | |
|
Guey S, Kraemer M, Hervé D, Ludwig T, Kossorotoff M, Bergametti F, Schwitalla JC, Choi S, Broseus L, Callebaut I, et al: Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 25:995–1003. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Zhang ZS, Liu W, Yang WZ, Dong ZN, Ma MJ, Han C, Yang H, Cao WC and Duan L: Association of a functional polymorphism in the MMP-3 gene with Moyamoya disease in the Chinese Han population. Cerebrovasc Dis. 30:618–625. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hishikawa T, Tokunaga K, Sugiu K and Date I: Assessment of the difference in posterior circulation involvement between pediatric and adult patients with moyamoya disease. J Neurosurg. 119:961–965. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimura M and Tominaga T: Lessons learned from moyamoya disease: Outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo). 52:327–332. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mugikura S, Takahashi S, Higano S, Shirane R, Sakurai Y and Yamada S: Predominant involvement of ipsilateral anterior and posterior circulations in moyamoya disease. Stroke. 33:1497–1500. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mugikura S, Takahashi S, Higano S, Shirane R, Kurihara N, Furuta S, Ezura M and Takahashi A: The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol. 20:336–343. 1999.PubMed/NCBI | |
|
Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T and Yoshimoto T: Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis. 20:347–354. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, Jeon P, Kim JS, Hong SC and Bang OY: High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke. 45:2457–2460. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, Kang E and Lee DS: Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke. 36:1485–1489. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka Y, Nariai T, Nagaoka T, Akimoto H, Ishiwata K, Ishii K, Matsushima Y and Ohno K: Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography. J Cereb Blood Flow Metab. 26:291–300. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Federau C, Christensen S, Zun Z, Park SW, Ni W, Moseley M and Zaharchuk G: Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide. Neuroradiology. 59:5–12. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JC, Liu B, Li ZW, Yu JS, He Y and Chen RD: Using CT perfusion imaging to evaluate the effect of STA-MCA bypass on hemorrhagic moyamoya disease. Chin J Neurosurg. 25:537–540. 2009. | |
|
Wang B, Zhou Q, Yao ZW, Li ZY and He GW: CTP and PWI in assessment of the effect of cerebral revascularization for moyamoya disease. Chin Comput Med imag. 21:64–68. 2015. | |
|
Nakagawara J: Reconsideration of hemodynamic cerebral ischemia using recent PET/SPECT studies. Trends in Cerebrovascular Surgery (Springer). 99–108. 2016. View Article : Google Scholar | |
|
Takagi Y, Kikuta K, Nozaki K, Fujimoto M, Hayashi J, Imamura H and Hashimoto N: Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease. Neurosurgery. 60:338–345. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Takagi Y, Kikuta K, Nozaki K and Hashimoto N: Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo). 47:1–4. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chmelova J, Kolar Z, Prochazka V, Curik R, Dvorackova J, Sirucek P, Kraft O and Hrbac T: Moyamoya disease is associated with endothelial activity detected by anti-nestin antibody. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 154:159–162. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, et al: Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 84:617–627. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar AH and Caplice NM: Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol. 30:1080–1087. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, Kim SJ, Kim YH, Kim YY, Cho BK, et al: Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res. 88:510–518. 2010.PubMed/NCBI | |
|
Lee JY, Moon YJ, Lee HO, Park AK, Choi SA, Wang KC, Han JW, Joung JG, Kang HS, Kim JE, et al: Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric moyamoya disease. Arterioscler Thromb Vasc Biol. 35:1670–1677. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, Kim KH, Jeon P, Kim JS, Hong SC and Lee KH: Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: A prospective study. Stroke. 41:173–176. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sigdel TK, Shoemaker LD, Chen R, Li L, Butte AJ, Sarwal MM and Steinberg GK: Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis. 8:452013. View Article : Google Scholar : PubMed/NCBI | |
|
Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, Sugiyama K and Kurisu K: Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev. 31:77–81. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Furuno A, Watari K, Nakamura M, Fukunaga Y, Jung JH and Ono M: A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells. Int J Oncol. 38:493–501. 2011.PubMed/NCBI | |
|
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK and Kim SK: Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 81:673–678. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ, Kim SK, Wang KC, Bang JS, Kang HS, Kim JE and Oh CW: Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry. 85:726–731. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fung LW, Thompson D and Ganesan V: Revascularisation surgery for paediatric moyamoya: A review of the literature. Childs Nerv Syst. 21:358–364. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP and Steinberg GK: Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 111:927–935. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, Zipfel GJ, Dacey RG Jr and Derdeyn CP: Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 37:1490–1496. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG and Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 100 (2 Suppl Pediatrics):S142–S149. 2004. | |
|
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J and Takahashi JC; JAM Trial Investigators, : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: Results of the Japan Adult Moyamoya Trial. Stroke. 45:1415–1421. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wan M and Duan L: Recent progress in hemorrhagic moyamoya disease. Br J Neurosurg. 29:189–191. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Z, Ding X, Men W, Zhang D, Zhao Y, Wang R, Wang S and Zhao J: Clinical features and outcomes in 154 patients with haemorrhagic moyamoya disease: Comparison of conservative treatment and surgical revascularization. Neurol Res. 37:886–892. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SU, Oh CW, Kwon OK, Bang JS, Ban SP, Byoun HS and Kim T: Surgical treatment of adult moyamoya disease. Curr Treat Options Neurol. 20:222018. View Article : Google Scholar : PubMed/NCBI | |
|
Kawashima A, Kawamata T, Yamaguchi K, Hori T and Okada Y: Successful superficial temporal artery-anterior cerebral artery direct bypass using a long graft for moyamoya disease. Neurosurgery. 67 (3 Suppl Operative):ons145–ons149. 2010.PubMed/NCBI | |
|
Hayashi T, Shirane R and Tominaga T: Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: The effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: Technical case report. Neurosurgery. 64:E195–E196. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Karasawa J, Kikuchi H, Furuse S, Sakaki T and Yoshida Y: A surgical treatment of ‘moyamoya’ disease ‘encephalo-myo synangiosis’. Neurol Med Chir (Tokyo). 17:29–37. 1977. View Article : Google Scholar : PubMed/NCBI | |
|
Matsushima Y, Aoyagi M, Koumo Y, Takasato Y, Yamaguchi T, Masaoka H, Suzuki R and Ohno K: Effects of encephalo-duro-arterio-synangiosis on childhood Moyamoya patients. Neurol Med Chir (Tokyo). 31:708–714. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Endo M, Kawano N, Miyaska Y and Yada K: Cranial burr hole for revascularization in moyamoya disease. J Neurosurg. 71:180–185. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Kinugasa K, Mandai S, Tokunaga K, Kamata I, Sugiu K, Handa A and Ohmoto T: Ribbon enchephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surg Neurol. 41:455–461. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Kuroda S, Houkin K, Ishikawa T, Nakayama N and Iwasaki Y: Novel bypass surgery for moyamoya disease using pericranial flap: Its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 66:1093–1101. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Karasawa J, Kikuchi H, Kawamura J and Sakai T: Intracranial transplantation of the omentum for cerebrovascular moyamoya disease: A two-year follow-up study. Surg Neurol. 14:444–449. 1980.PubMed/NCBI | |
|
Kim H, Jang DK, Han YM, Sung JH, Park IS, Lee KS, Yang JH, Huh PW, Park YS, Kim DS and Han KD: Direct bypass versus indirect bypass in adult moyamoya angiopathy with symptoms or hemodynamic instability: A meta-analysis of comparative studies. World Neurosurg. 94:273–284. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Iwama T, Hashimoto N and Yonekawa Y: The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery. 38:1120–1126. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Mukerji N, Cook DJ and Steinberg GK: Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease? J Neurosurg. 122:90–94. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimura M, Mugikura S, Kaneta T, Shimizu H and Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 71:442–447. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kaku Y, Iihara K, Nakajima N, Kataoka H, Fukuda K, Masuoka J, Fukushima K, Iida H and Hashimoto N: Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease. J Cereb Blood Flow Metab. 32:2066–2075. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K and Tamaki N: Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: A serial single photon emission CT/positron emission tomography study. Stroke. 43:2610–2616. 2012. View Article : Google Scholar : PubMed/NCBI |
